Selected article for: "cardiovascular disease and high risk"

Author: Bersanelli, Melissa; Zielli, Teresa; Perrone, Fabiana; Casartelli, Chiara; Pratticò, Fabiana; Rapacchi, Elena; Camisa, Roberta; Tognetto, Michele; Clemente, Alberto; Giannarelli, Diana; Rebuzzi, Sara Elena; Leonetti, Alessandro; Bordi, Paola; Tiseo, Marcello; Buti, Sebastiano
Title: Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy
  • Cord-id: 0bmcw303
  • Document date: 2020_9_16
  • ID: 0bmcw303
    Snippet: Aim: Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients & methods: We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. Results: Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, w
    Document: Aim: Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients & methods: We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. Results: Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure. Conclusion: Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

    Search related documents:
    Co phrase search for related documents